Clincosm LogoSign in Get a demo

hodgkin's lymphoma

Showing 1 - 25 of 96
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Communication Skills Intervention to Promote Transition Into

Active, not recruiting
  • Hodgkin's Lymphoma
  • Diffuse Large B-cell Lymphoma
    • Tampa, Florida
    • +8 more
    Dec 19, 2022

    Hodgkin's Lymphoma, Primary Mediastinal Large B-cell Lymphoma (PMBCL) Trial in Worldwide (Pembrolizumab)

    Active, not recruiting
    • Hodgkin's Lymphoma
    • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
    • Pembrolizumab
    • Torrance, California
    • +26 more
    Oct 20, 2022

    Hodgkin's Lymphoma Trial in Houston (Azacytidine, Pembrolizumab)

    Recruiting
    • Hodgkin's Lymphoma
    • Houston, Texas
      MD Anderson Cancer Center
    Oct 5, 2022

    Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Bethesda, Minneapolis (biological, drug,

    Recruiting
    • Myelodysplastic Syndrome
    • +4 more
    • Rituximab
    • +6 more
    • Bethesda, Maryland
    • +1 more
    Aug 20, 2022

    Microsatellite High Cancers, Peritoneal Mesothelioma, Extrapulmonary High Grade Trial in Houston (XmAb20717)

    Recruiting
    • Microsatellite High Cancers
    • +7 more
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 8, 2022

    Hodgkin's Lymphoma Trial in Seattle (Pembrolizumab, Umbralisib)

    Terminated
    • Hodgkin's Lymphoma
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 22, 2022

    Radiation-Induced Cardiac Injury in Hodgkin Lymphoma Treated

    Completed
    • Hodgkin's Lymphoma
    • Cardiac Magnetic Resonance Imaging
    • Echocardiogram
    • Jacksonville, Florida
      University of Florida Health Proton Therapy Institute
    Jun 9, 2022

    Hematological Malignancies, Multiple Myeloma, Hodgkin's Lymphoma Trial in Worldwide (Tinostamustine)

    Recruiting
    • Hematological Malignancies
    • +3 more
    • Phoenix, Arizona
    • +19 more
    Apr 12, 2022

    Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Atlanta (Fludarabine, Melphalan,

    Completed
    • Chronic Myelogenous Leukemia
    • +9 more
    • Atlanta, Georgia
      Northside Hospital
    Apr 4, 2022

    Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in Chapel Hill, Houston (CAR.CD30 T cells)

    Active, not recruiting
    • Non-Hodgkin's Lymphoma
    • Hodgkin's Lymphoma
    • CAR.CD30 T cells
    • Chapel Hill, North Carolina
    • +2 more
    Mar 16, 2022

    Longitudinal Sexual and Reproductive Health Study of Breast

    Recruiting
    • Breast Cancer
    • +2 more
    • surveys
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Mar 1, 2022

    AML - Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome), Mixed Phenotype Acute Leukemia Trial in Palo Alto (T-allo10)

    Recruiting
    • AML - Acute Myeloid Leukemia
    • +5 more
    • T-allo10
    • Palo Alto, California
      Lucile Packard Children's Hospital
    Feb 2, 2022

    Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Houston (autologous CAR.CD30 EBV specific-CTLs)

    Active, not recruiting
    • Hodgkin's Lymphoma
    • Non-Hodgkin's Lymphoma
    • autologous CAR.CD30 EBV specific-CTLs
    • Houston, Texas
    • +1 more
    Feb 4, 2022

    Hodgkin's Lymphoma Trial in Milan (histone deacetylase inhibitor (ITF2357))

    Terminated
    • Hodgkin's Lymphoma
    • histone deacetylase inhibitor (ITF2357)
    • Milan, Italy
      Istituto Nazionale per lo studio e la cura dei Tumori
    Jan 18, 2022

    Hodgkin's Lymphoma Trial in Poland (drug, diagnostic test, procedure)

    Recruiting
    • Hodgkin's Lymphoma
    • Bydgoszcz, Poland
    • +12 more
    Dec 23, 2021

    Hodgkin's Lymphoma, Lymphoid Leukemia, Lymphoma Trial in Richmond (mycophenolate mofetil, Sargramostim, Filgrastim)

    Active, not recruiting
    • Hodgkin's Lymphoma
    • +17 more
    • mycophenolate mofetil
    • +2 more
    • Richmond, Virginia
      Virginia Commonwealth University/Massey Cancer Center
    Dec 21, 2021

    Hodgkin's Lymphoma, Lymphoma, Non-Hodgkin Trial in Ann Arbor (Bortezomib, Ruxolitinib)

    Completed
    • Hodgkin's Lymphoma
    • Lymphoma, Non-Hodgkin
    • Ann Arbor, Michigan
      University of Michgan Comprehensive Cancer Center
    Dec 3, 2021

    Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Acute Myeloid Leukaemia Trial in United Kingdom (Reduced intensity haplodentical

    Active, not recruiting
    • Hodgkin's Lymphoma
    • +8 more
    • Reduced intensity haplodentical stem cell transplant
    • Myeloablative haploidentical stem cell transplant
    • Birmingham, United Kingdom
    • +11 more
    Sep 27, 2021

    Hodgkin's Lymphoma Trial in Milano (ITF2357)

    Completed
    Has Results
    • Hodgkin's Lymphoma
    • Milano, Italy
      Istituto Nazionale per la Cura e lo Studio dei Tumori
    Apr 20, 2021

    Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Morgantown (Busulfan, Fludarabine)

    Active, not recruiting
    • Hodgkin's Lymphoma
    • Non-Hodgkin's Lymphoma
    • Morgantown, West Virginia
      West Virginia University Hospitals Mary Babb Randolph Cancer Cen
    Apr 6, 2021

    Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in New York (Bendamustine, Carmustine, Etoposide)

    Completed
    Has Results
    • Hodgkin's Lymphoma
    • Non-Hodgkin's Lymphoma
    • New York, New York
      Weill Cornell Medical College
    Feb 1, 2021

    Hodgkin's Lymphoma Trial in Houston (Panobinostat, Ifosfamide, Mesna)

    Completed
    Has Results
    • Hodgkin's Lymphoma
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 10, 2020

    Hodgkin's Lymphoma Trial in Shijiazhuang (biological, drug, procedure)

    Recruiting
    • Hodgkin's Lymphoma
    • Auto CAR-T
    • +2 more
    • Shijiazhuang, Hebei, China
      Hematology Department, Hebei Medical University Fourth Hospital
    Dec 24, 2020

    Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Myeloid Leukemia Trial in Detroit (Dasatinib, laboratory biomarker analysis)

    Terminated
    • Non-Hodgkin's Lymphoma
    • +5 more
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    Dec 14, 2020

    Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in Worldwide (HCD122)

    Completed
    • Non-Hodgkin's Lymphoma
    • Hodgkin's Lymphoma
    • Chicago, Illinois
    • +27 more
    Dec 11, 2020